PulseAugur
EN
LIVE 23:27:16

AI predicts brain tumor enhancement from non-contrast MRI, outperforming radiologists

Researchers have developed a deep learning model capable of predicting brain tumor enhancement from non-contrast MRI scans, potentially reducing the need for contrast agents. The model, trained on over 11,000 studies, achieved 83.0% balanced accuracy in detecting enhancement, outperforming eleven expert radiologists who achieved 71.7% accuracy under blinded conditions. This AI shows promise as a decision-support tool, particularly for flagging studies likely to show enhancement and lessening gadolinium dependence in neuro-oncology. AI

IMPACT This AI model could streamline neuro-oncology imaging workflows and reduce patient exposure to contrast agents.

RANK_REASON The cluster is based on a research paper detailing a new AI model and its performance on a diagnostic task. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.CV →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI predicts brain tumor enhancement from non-contrast MRI, outperforming radiologists

COVERAGE [1]

  1. arXiv cs.CV TIER_1 English(EN) · James K Ruffle, Samia Mohinta, Guilherme Pombo, Asthik Biswas, Alan Campbell, Indran Davagnanam, David Doig, Ahmed Hammam, Harpreet Hyare, Farrah Jabeen, Emma Lim, Dermot Mallon, Stephanie Owen, Sophie Wilkinson, Sebastian Brandner, Parashkev Nachev ·

    Predicting brain tumour enhancement from non-contrast MR imaging with artificial intelligence: a multi-cohort retrospective diagnostic accuracy study

    arXiv:2508.16650v3 Announce Type: replace-cross Abstract: Brain tumour MRI typically requires both pre- and post-contrast imaging, but gadolinium is not always desirable (frequent follow-up, renal impairment, allergy, paediatric patients). We developed and validated a deep learni…